Application 062483

Type
ANDA
Sponsor
VALEANT LUXEMBOURG

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GRIFULVIN VGRISEOFULVIN, MICROSIZESUSPENSION;ORAL125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
42762SUPPL2005-07-22
22264SUPPL2003-08-05
22263SUPPL2003-08-05
22262SUPPL2003-08-05
22261SUPPL2003-08-05
22260SUPPL2003-08-05
22259SUPPL2003-08-05
22258SUPPL2003-08-05
42761SUPPL2003-07-31
42760SUPPL2003-07-31
22269SUPPL2003-07-31
22268SUPPL2003-07-31
22267SUPPL2003-07-31
22266SUPPL2003-07-31
22265SUPPL2003-07-31
22257ORIG2003-07-31